On Nov. 5, 2021, the U.S. Food and Drug Administration The FDA issued an emergency use authorization (EUA) for the iHealth COVID-19 Antigen Rapid Test, an OTC COVID-19 antigen diagnostic test that delivers results in 15 minutes.

The company anticipated producing 100 million tests per month, with capacity increasing to 200 million per month in early 2022.